Quarterly report pursuant to Section 13 or 15(d)

Securities Financing Agreements, Collateral and Restricted Cash - Securities Financing Agreements (Details)

v3.24.3
Securities Financing Agreements, Collateral and Restricted Cash - Securities Financing Agreements (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Securities borrowed or purchased under agreements to resell    
Gross Assets/Liabilities $ 787,415 $ 703,641
Amounts Offset (449,709) (423,017)
Net Balance Sheet Amount 337,706 280,624
Financial Instruments (308,690) (257,541)
Net Assets/Liabilities 29,016 23,083
Securities loaned or sold under agreements to repurchase    
Gross Liabilities 847,667 706,904
Amounts Offset (449,709) (423,017)
Net Balance Sheet Amount 397,958 283,887
Financial Instruments (380,426) (272,285)
Net Liabilities 17,532 11,602
Other    
Gross Liabilities 13,983 10,066
Amounts Offset 0 0
Net Balance Sheet Amount 13,983 10,066
Financial Instruments (13,983) (10,066)
Net Liabilities 0 0
Total Securities Financing Agreements Liability    
Gross Liabilities 861,650 716,970
Amounts Offset (449,709) (423,017)
Net Balance Sheet Amount 411,941 293,953
Financial Instruments (394,409) (282,351)
Net Liabilities 17,532 11,602
Loans and leases repurchase activity $ 14,100 $ 8,700